• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Japan - Otsuka inks agreement to deliver psychiatric medicines

makoto

makoto

Well-known member
Otsuka inks agreement to deliver psychiatric medicines

Otsuka Pharmaceutical Co. and H. Lundbeck A/S signed an agreement on Nov. 11 in Tokushima, Japan, to develop and commercialize worldwide up to five psychiatric and neuroscience products.
http://ajw.asahi.com/article/economy/biz_briefs/AJ2011111117192
press release http://www.otsuka.co.jp/en/release/2011/1111_01.html

Otsuka to Develop Mental Disease Drugs with Danish Firm

Tokyo, Nov. 11 (Jiji Press)--Otsuka Pharmaceutical Co. said Friday that it has formed an alliance with Danish drug maker Lundbeck AS for research and development of drugs for central nervous system diseases.

http://jen.jiji.com/jc/eng?g=ind&k=2011111100797

Otsuka ties up with Denmark's Lundbeck on psychiatric drugs

TOKYO (Kyodo) -- Otsuka Pharmaceutical Co. and Danish drugmaker H. Lundbeck A/S announced Friday an agreement to share costs to develop and market drugs to treat central neurological diseases including schizophrenia.

http://mdn.mainichi.jp/mdnnews/business/archive/news/2011/11/12/20111112p2g00m0bu056000c.html
 
You must log in or register to reply here.
Back
Top Bottom